Skip to main content
OpenTrials

Clinical trial condition

Measles

Explore clinical trials studying Measles. Study availability and eligibility vary by location and protocol.

101 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Measles trial results

Completed

Ontogeny of Measles Immunity in Infants

NCT00240916

Conditions
Infections, Measles, Mononegavirales Infections, +4 more
Locations
  • Palo Alto Medical Foundation/Department of Pediatrics Palo Alto, California, United States
  • Stanford University School of Medicine Stanford, California, United States
View Trial Details
Completed

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

NCT00013871

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +38 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
View all 40 locations
View Trial Details
Completed

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

NCT00000815

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +18 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
View all 46 locations
View Trial Details
Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

NCT02184572

Conditions
Infections, Measles, Measles-Mumps-Rubella Vaccine, +16 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
View all 95 locations
View Trial Details

Related conditions